ascopubs.org

The association of adaptive early phase study design and late phase study results in oncology using clinicaltrials.gov data.

Informed consent in phase I clinical trials: Implications for trends in design. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a full text ...
ascopubs.org

Adaptive Cohort Size Determination Method for Bayesian Optimal Interval Phase I/II Design to Shorten Clinical Trial Duration

Improved Cancer-Specific Risk Stratification by the Lymph Node Ratio-Based Nomogram: A Potential Role in Guiding Postoperative Management Decisions for Oral Cavity Carcinoma We propose a novel ...
Cure Today

Adaptive NSCLC Study Fails to Produce Improved Results, Clinical Benefits in Some

Imfinzi with monalizumab and ceralasertib showed promising long-term benefits in advanced NSCLC, but no other combinations significantly improved results. Long-term benefits were improved in some ...
Morningstar

Global Coalition for Adaptive Research Announces Initiation of AZD1390 in GBM AGILE Trial

Global Coalition for Adaptive Research (GCAR) is a 501 (c) (3) non-profit corporation uniting physicians, clinical researchers, advocacy and philanthropic organizations, biotech/pharma companies, ...